Chapter 482

The origins of fetal cardiology were in the novel and still relevant fetal lamb investigations of Rudolph and Heymann.1-3 From these early studies we began to understand normal fetal cardiovascular physiology and developed hypotheses regarding the evolution of congenital heart disease (CHD) in utero and its influence on fetal circulation.4 With advances in ultrasound technology in the late 1970s and 1980s, it became possible to demonstrate normal fetal cardiac anatomy and document growth of the cardiac chambers and great arteries.5-9 Doppler investigations in the 1980s and 1990s added insight into developmental changes in normal human fetal circulation and cardiovascular function.10-13 Initial reports describing prenatal detection of fetal CHD documented a more severe spectrum of disease than that encountered after birth.14-16 This was at least in part a consequence of the ease with which the more severe pathology, including fetal hydrops, was recognized at routine ultrasound assessment.

Advances in ultrasound technology over the past 20 years have led to monumental improvements in our ability to define fetal cardiovascular anatomy and to evaluate normal and altered myocardial function in greater detail.To date, most forms of CHD, both major and minor, have been detected prenatally. It has even become possible to define fetal cardiovascular anatomy and function and to detect abnormalities of cardiovascular structure, function, and rhythm as early as 10 to 14 weeks of gestation, only a short time after completion of cardiac morphogenesis. With rapid advances in technology, fetal cardiology has evolved as its own subspecialty that merges maternal-fetal medicine and pediatric cardiology. This chapter reviews unique aspects of this field and its role in the management of neonates with significant structural and functional CHD.

Pregnancies at increased risk for fetal congenital heart disease (CHD), whether structural, functional, or rhythm related, are evaluated by the fetal echocardiogram. Indications for fetal echocardiography include maternal diseases associated with fetal CHD (eg, maternal diabetes, phenylketonuria, and autoimmune pathology), maternal infection, and maternal exposure to medications known to be teratogenic for the developing fetal heart. Fetal indications include a suspected cardiac abnormality at routine ultrasound; a suspected extracardiac abnormality in the fetus, including a chromosomal abnormality known to be associated with CHD; an abnormal fetal rhythm; and conditions associated with altered fetal heart function (eg, twin-twin transfusion syndrome, acardiac twins, anemia). A family history of CHD (mother, father, or sibling) or of a syndrome associated with CHD are also indications. Although many pregnancies are referred as a consequence of maternal disease or a family history of CHD, the majority of positive referrals (pregnancies with fetal CHD) come from the low-risk population and are referred because of a suspicion of CHD during routine ultrasound assessment.17-18 Recognition of this has prompted educational initiatives to train obstetrical ultrasound personnel for better screening of the heart at the time of routine obstetrical scanning.

Pregnancies at risk for fetal CHD as a consequence of a known family history and maternal disease are ...

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

## Subscription Options

### AccessPediatrics Full Site: One-Year Subscription

Connect to the full suite of AccessPediatrics content and resources including 20+ textbooks such as Rudolph’s Pediatrics and The Pediatric Practice series, high-quality procedural videos, images, and animations, interactive board review, an integrated pediatric drug database, and more.